Yeung Man Lung, Houzet Laurent, Yedavalli Venkat S R K, Jeang Kuan-Teh
Molecular Virology Section, Laboratory of Molecular Microbiology, NIAID, National Institutes of Health, Bethesda, Maryland 20892-0460, USA.
J Biol Chem. 2009 Jul 17;284(29):19463-73. doi: 10.1074/jbc.M109.010033. Epub 2009 May 20.
Short interfering RNAs (siRNAs) have been used to inhibit HIV-1 replication. The durable inhibition of HIV-1 replication by RNA interference has been impeded, however, by a high mutation rate when viral sequences are targeted and by cytotoxicity when cellular genes are knocked down. To identify cellular proteins that contribute to HIV-1 replication that can be chronically silenced without significant cytotoxicity, we employed a shRNA library that targets 54,509 human transcripts. We used this library to select a comprehensive population of Jurkat T-cell clones, each expressing a single discrete shRNA. The Jurkat clones were then infected with HIV-1. Clones that survived viral infection represent moieties silenced for a human mRNA needed for virus replication, but whose chronic knockdown did not cause cytotoxicity. Overall, 252 individual Jurkat mRNAs were identified. Twenty-two of these mRNAs were secondarily verified for their contributions to HIV-1 replication. Five mRNAs, NRF1, STXBP2, NCOA3, PRDM2, and EXOSC5, were studied for their effect on steps of the HIV-1 life cycle. We discuss the similarities and differences between our shRNA findings for HIV-1 using a spreading infection assay in human Jurkat T-cells and results from other investigators who used siRNA-based screenings in HeLa or 293T cells.
短干扰RNA(siRNA)已被用于抑制HIV-1复制。然而,RNA干扰对HIV-1复制的持久抑制受到了阻碍,原因在于靶向病毒序列时的高突变率以及敲低细胞基因时的细胞毒性。为了鉴定有助于HIV-1复制且能在无明显细胞毒性的情况下被长期沉默的细胞蛋白,我们采用了一个靶向54,509个人类转录本的shRNA文库。我们利用该文库筛选出了一群全面的Jurkat T细胞克隆,每个克隆表达一种单一的离散shRNA。然后用HIV-1感染这些Jurkat克隆。在病毒感染中存活下来的克隆代表了那些因沉默一种病毒复制所需的人类mRNA而形成的部分,但对其长期敲低不会导致细胞毒性。总体而言,共鉴定出252个单独的Jurkat mRNA。其中22个mRNA对HIV-1复制的贡献得到了二次验证。对5个mRNA,即NRF1、STXBP2、NCOA3、PRDM2和EXOSC5,研究了它们对HIV-1生命周期各步骤的影响。我们讨论了在人类Jurkat T细胞中使用传播感染试验得到的针对HIV-1的shRNA研究结果与其他研究人员在HeLa或293T细胞中使用基于siRNA的筛选得到的结果之间的异同。